Global Drug R&D Express (October 2024)

This report compiles and summarizes the basic information of all the first-to-market and special review drugs globally for the month of October totaling 132 drugs. Among them, 1 first-to-market drugs and 1 drugs under special review were selected for detailed analysis. The report provides an in-depth interpretation of these drugs, covering various aspects such as basic information, development status, technological barriers, mechanism of action, clinical trials, and competitive landscape.